Collaborating Institutes

FOREIGN UNIVERSITIES, HOSPITALS, COMPANIES AND RESEARCH INSTITUTES:

  1. MRC, Leicester, UK (RA Knight, M Malewicz, A. Antonov, A Rufini, A Willis) Since 2000. Cell Death and cancer.
  2. University Ghent, Belgium (P Vandenabeele). Since 2010 Epithelial stem cells.
  3. Instit Technology, University St. Petersburg, Russia (A Garabadzhiu). Since 2011 Cancer transcriptomes.
  4. DZNE, Bonn, Deutschland (P Nicotera, D Bano). Since 2009. p73 and neurodegeneration.
  5. Campbell Institute, Univ Toronto, Canada (TW Mak). Since 2004. Transgenic mouse models.
  6. SIBS, Shanghai, China (Y Shi). Since 2008. Cancer and metabolomes.
  7. Institute Advance Science, Princeton, NJ, USA (A Levine). Since 2000. Bioinformatics.
  8. St. Jude Hospital, Memphis, TN, USA (DR Green). Since 2000. Cell death.
  9. University College London, UK (Salomoni). Since 2000 Cell cycle.
  10.  Aarhus University, Danimarca (Knudsen). Since 2007 Topoisomerase from Plasmodium falciparum.
  11. NIH Bethesda (Pommier). Farmacogenomics: DNA and Topoisomerases as Targets of Anticancer Drugs.

ITALIAN UNIVERSITIES, HOSPITALS, COMPANIES AND RESEARCH INSTITUTES:

  1. IDI-IRCCS. Since 2000 Meccanismi molecolari nelle patologie dermatologiche.
  2. Istituto Nazionale Tumori”-IRCCS “Fondazione Pascale”, Napoli (Ciliberto). Since 2011 Terapia genica.
  3. CNR (Peschiaroli). Since 2011. Degradazione proteica e ciclo cellulare.
  4. CASPUR (Chillemi). Since 2002. Dinamica Molecolare per la simulazione di sistemi biologici.
  5. BioUniverSA, Universita’ Salerno (Melino). Since 2011. Biotecnologie applicate alla salute dell’uomo.
  6. Università Bologna (Capranico). Since 2004. Topoisomerasi e nuove strategie terapeutiche dei tumori.
  7. CNR (Fiorani) Struttura e Funzione della topoisomerasi I umana.
  8. Istituto Regina Elena (S Soddu) Since 2017. Oncologia Sperimentale.
  9. Istituto Regina Elena (G Blandino) Since 2017. Oncogenomica traslazionale.

 

Comments are closed.